Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
about
Iron Oxide as an MRI Contrast Agent for Cell TrackingNoninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.In vivo imaging of therapy-induced anti-cancer immune responses in humans.K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.In vivo MRI cell tracking: clinical studiesCytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Transplanted adipose-derived stem cells can be short-lived yet accelerate healing of acid-burn skin wounds: a multimodal imaging study.Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination.MRl of prostate cancer antigen expression for diagnosis and immunotherapy.Monitoring the efficacy of dendritic cell vaccination by early detection of (99m) Tc-HMPAO-labelled CD4(+) T cells.Improvement of different vaccine delivery systems for cancer therapy.Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells.Molecular imaging of cell-based cancer immunotherapy.Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responsesScience to practice: can decreased lymph node MR imaging signal intensity be used as a biomarker for the efficacy of cancer vaccination?Influence of synthetic superparamagnetic iron oxide on dendritic cells.Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxideIn vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin.Animal models and molecular imaging tools to investigate lymph node metastasesFunctionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigenDesign of targeted cardiovascular molecular imaging probes.Magnetic nanoparticles for imaging dendritic cellsTracking immune cells in vivo using magnetic resonance imaging.Imaging the immune response to monitor tumor immunotherapy.In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence.The evolution of imaging in cancer: current state and future challenges.Noninvasive cell-tracking methods.Magnetic nanoparticles for cancer diagnosis and therapy.Principles and emerging applications of nanomagnetic materials in medicine.Dendritic cell therapy for Type 1 diabetes suppression.Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging.Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice.Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner.DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control.MRI of prostate stem cell antigen expression in prostate tumors.Cell quantification: evolution of compartmentalization and distribution of iron-oxide particles and labeled cells.
P2860
Q26781657-E1DECA41-7BB2-4768-A9B1-6D20719BA801Q26822871-3DAF1604-7EF2-418D-A3F3-BE3DF9D19C5DQ26830028-586F4AA5-DDC9-486F-9E7B-2C0EEDE701A0Q27693338-7757C5D3-A1F2-4B59-AE27-EE98ED871622Q33584244-34802801-96A2-4183-A23E-9D288546BB5BQ33803809-3C386F11-C28E-4240-962D-5FA41E3D0867Q33875615-A7BBF6D0-E649-414B-A160-115C2F5BB2A3Q33875794-903F9A5B-6C8F-4591-AB2B-0E90A7F75156Q33921059-F667D799-A864-43BB-960A-BB91D8C02A1FQ34325715-8E5415D2-06D5-4782-912D-1E900FC23769Q34413415-B4B46D00-177D-4A2C-900C-ABA87A0F8EB8Q34506877-39629543-A436-4A03-A054-AA51E926B4EDQ34544040-BD502132-4992-4F17-84D3-E4C7D68FBC96Q34717870-F09F684D-E3B7-4036-AB19-70BC26441062Q34995056-126ADD8B-511C-438C-B901-1BE6B83D3E02Q35053273-88FE0F71-DB38-4AAF-9509-02DD04BA103BQ35108656-B0A8F4DC-CC2C-454F-8F4F-73EC05DC43C7Q35254464-BACBDFE0-D440-48EA-951B-9BDB0C77B662Q35412152-4AC23205-C7A5-4406-8C23-1DFA6680C9BAQ35556913-2D0FFC53-A64A-426F-9FB4-6AF9620C5809Q35629266-9A46B337-9207-4892-82AE-6089F94067CBQ35720139-55175BCF-DB5E-423F-8054-90B984FDA303Q36665051-5E6A9085-11CD-4246-B18B-E220696493E1Q36777401-EA0A65FA-C092-4D5E-8767-10C3E68E9E16Q36956278-97C0BA29-D44E-4119-9CCB-C7207C1AE568Q37455363-05A7EB7C-2784-452A-98DA-5A1BCACC51E2Q37608319-9C5AB3AB-99A3-478A-8136-0AA53A769830Q37702208-95DF8045-9F4E-40E3-89BA-65D6657406B5Q37848518-C62320C2-21E4-415D-B355-5025E97A3DDEQ37938642-EB33BD07-0EAF-4E25-86B6-A8117AE6DFB5Q37978479-D8ECBA9A-F5B0-4D51-A7D8-893B64D63754Q38001396-2139B593-73D0-430C-B19D-46ECC8A3BEEAQ38059518-A39A9F9F-E558-4436-8B45-559EDAF476F8Q38103222-7056FFF3-5549-4559-B566-168D4C415899Q38243329-2C7CAB6C-E8BF-4DD5-B0E1-4907BE81AD06Q38468002-D3289472-8423-4091-8B74-060848755424Q38469509-59EC8F13-AAA3-4AA4-B6D3-5F4E0FAEF1BAQ38786910-747572D5-551D-406A-B250-3D426C1E02C1Q39342217-717B70F7-75C2-4C1D-9AF9-79231F8C2FB2Q39376137-3C64BBC7-D9F8-4DB1-8E00-F0D46E43EDBF
P2860
Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@ast
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@en
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@nl
type
label
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@ast
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@en
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@nl
prefLabel
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@ast
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@en
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@nl
P2093
P2860
P1433
P1476
Magnetovaccination as a novel ...... e and delivery to lymph nodes.
@en
P2093
Christopher M Long
Hanneke W M van Laarhoven
Hyam I Levitsky
Jeff W M Bulte
P2860
P304
P356
10.1158/0008-5472.CAN-08-3691
P407
P577
2009-03-10T00:00:00Z